You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
輝瑞美國主要工廠遭龍捲風摧毀 加劇藥品短缺問題
阿思達克 07-22 01:47
輝瑞(PFE.US)位於美國北卡羅來納州的藥廠於龍捲風中遭受嚴重破壞,或加劇全國範圍內本已嚴重的藥品短缺問題。 該藥廠負責生產輝瑞四分之一用於美國醫院的無菌注射劑,輝瑞在一份聲明中表示,工廠所有員工均安全,正評估損失以確定對生產的影響。 據猶他大學藥物信息服務中心數據,美國至少有129種無菌注射藥物出現供應短缺,其中包括主流抗癌藥物cisplatin和carboplatin。據輝瑞公司網站稱,涉事工廠生產多種藥物,包括麻醉劑和抗感染藥物。 美國食品和藥物管理局表示正在評估情況,並將與輝瑞合作,了解對國家藥品供應的任何潛在影響。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account